The global continuous glucose monitoring systems market is on the brink of extraordinary growth, with recent reports highlighting a substantial increase in market value. The market, estimated at USD 11.1 billion in 2023, is projected to soar to an impressive USD 103.5 billion by 2033, reflecting a robust compound annual growth rate (CAGR) of 25.1%.
This remarkable expansion underscores the growing importance of continuous glucose monitoring systems in the effective management of diabetes. With the rise in diabetes prevalence and the increasing adoption of advanced healthcare technologies, CGM systems are becoming essential tools for patients and healthcare providers alike.
As diabetes care evolves, CGM systems offer real-time glucose monitoring, enabling patients to manage their condition more effectively. This innovation not only enhances patient outcomes but also reduces the burden on healthcare systems.
The anticipated growth of the CGM market is driven by several factors, including technological advancements, increased awareness of diabetes management, and a surge in the demand for personalized healthcare solutions.
Industry experts believe that the continuous glucose monitoring systems market will play a pivotal role in transforming diabetes care, empowering patients with actionable insights and fostering better health outcomes.
Key Takeaways:
- The global CGM systems market is set to grow from USD 11.1 billion in 2023 to an estimated USD 103.5 billion by 2033, reflecting a CAGR of 25.1%.
- The rising prevalence of diabetes worldwide and increasing awareness about the benefits of CGM systems are the primary drivers of this growth.
- The Asia Pacific region is anticipated to experience the fastest market expansion, driven by a burgeoning diabetic population and improving healthcare systems.
- The growing geriatric population, increasing demand for better diabetes diagnostics, and the need to address unmet healthcare needs, particularly in developing regions, are also contributing to market growth.
Explore the High Demand for Continuous Glucose Monitoring Systems: Our Full Report Provides a Detailed Look at Emerging Trends!
Leading Market Players:
Prominent players driving the CGM systems market forward include Abbott, Herbalife Nutrition, GNC Holdings, NOW Health, and Nutramax Laboratories, among others. These companies are at the forefront of innovation, ensuring that CGM systems continue to evolve and meet the growing needs of the global diabetic population.
Market Segmentation:
By Components:
- Transmitters and Monitors
- Sensors
- Insulin Pumps
By End-use Sector:
- Home Care Diagnostics
- Hospitals
- ICU/Critical Care
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
